MYGN vs UTHR · rev $824.5M vs P/E 20, rev $1.56B
Myriad Genetics Inc (MYGN) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
MYGN currently screens at market cap $413.7M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the MYGN and UTHR stock pages for the full models.
Not investment advice.